دورية أكاديمية

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.

التفاصيل البيبلوغرافية
العنوان: Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.
المؤلفون: Li, Meng, Zhao, Hong, Zhang, Xiaosong, Wood, Laura D., Anders, Robert A., Choti, Michael A., Pawlik, Timothy M., Daniel, Hubert D., Kannangai, Rajesh, Offerhaus, G Johan A., Velculescu, Victor E., Wang, Linfang, Zhou, Shibin, Vogelstein, Bert, Hruban, Ralph H, Papadopoulos, Nick, Cai, Jianqiang, Torbenson, Michael S., Kinzler, Kenneth W.
المصدر: Nature Genetics; Sep2011, Vol. 43 Issue 9, p828-829, 2p, 2 Charts
مصطلحات موضوعية: CHROMATIN, LIVER cancer, NUCLEOTIDE sequence, HEPATITIS C virus, GENETIC mutation, HEPATITIS B virus, GENETICS
مصطلحات جغرافية: UNITED States, EUROPE
مستخلص: Through exomic sequencing of ten hepatitis C virus (HCV)-associated hepatocellular carcinomas (HCC) and subsequent evaluation of additional affected individuals, we discovered novel inactivating mutations of ARID2 in four major subtypes of HCC (HCV-associated HCC, hepatitis B virus (HBV)-associated HCC, alcohol-associated HCC and HCC with no known etiology). Notably, 18.2% of individuals with HCV-associated HCC in the United States and Europe harbored ARID2 inactivation mutations, suggesting that ARID2 is a tumor suppressor gene that is relatively commonly mutated in this tumor subtype. [ABSTRACT FROM AUTHOR]
Copyright of Nature Genetics is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index